Lidocaine: Effect of Lidocaine in Chronic Cough

Status Completed

Clinical Trial Summary

People cough in order to clear their airways. Most coughs are caused by viruses and settle down by themselves, but some people develop persistent coughing which can be anywhere from 8 weeks to several years. This is called chronic cough. People with chronic cough find the symptom distressing and it can have a major impact on their quality of life. Patients with chronic cough often report a sensation at the back of their throat which makes them feel an urge to cough. There is some evidence that Lidocaine (an anaesthetic used during medical procedures) can suppress a person's cough when given to patients via a nebuliser (a machine that turns liquid into a fine mist).

It is currently unknown whether using a local anaesthetic, such as Lidocaine, in the form of a throat spray would successfully suppress a person's cough. A throat spray would be an easier treatment option in chronic cough patients. Thus, the investigators research aims to compare cough rates, severity and urge to cough scores between Lidocaine throat spray and nebulised Lidocaine.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01252225
Study type	Interventional
Source	University Hospital of South Manchester NHS Foundation Trust
Contact
Status	Completed
Phase	Phase 4
Start date	February 2011
Completion date	May 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01432730` - A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)	Phase 2
Not yet recruiting	`NCT01413698` - Cough Count Validation	N/A
Completed	`NCT03639727` - Cough in Eastern and Central Finland	N/A
Completed	`NCT03696108` - A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)	Phase 3
Recruiting	`NCT03638063` - ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
Recruiting	`NCT06376448` - An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
Completed	`NCT03172130` - Sham CPAP vs. Straight CPAP for Chronic Cough	N/A
Recruiting	`NCT06286163` - Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
Completed	`NCT03622216` - A Dose Escalation Study of Bradanicline in Refractory Chronic Cough	Phase 2
Recruiting	`NCT05522699` - Cough Suppressive Therapy in Patients With Chronic Cough	N/A
Completed	`NCT01297790` - Cough Responses to Tussive Agents in Health and Disease	N/A
Completed	`NCT04193202` - Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)	Phase 3
Completed	`NCT01865422` - French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)	N/A
Completed	`NCT04525885` - A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension	Phase 3
Completed	`NCT04193176` - Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)	Phase 3
Recruiting	`NCT05362097` - Analysis of the Reliability and Validity of the Chinese Version of CC-QoL
Recruiting	`NCT03787511` - Chronic Cough and Small Fiber Neuropathy	N/A
Terminated	`NCT03864328` - A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF	Phase 2
Completed	`NCT05274516` - A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration	Phase 1
Not yet recruiting	`NCT01807832` - The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.	N/A